Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Sawgrass Asset Management - Large Cap Quality Growth. This analysis is provided for institutional research purposes only and is not investment advice.
"Outperforming the benchmark by 2.1% due to strong health care rotation and non-Mag7 tech stock gains, despite headwinds from software and defensive positions."
In 4Q25, the growth market gained 1.1% amid concerns over the Fed, economic stability, and the return on massive AI spending. The Sawgrass Large Cap Quality Growth portfolio outperformed, returning 3.2% (beating the Russell 1000 Growth Index by 2.1%). Strong contributors included non-Mag7 tech stocks (AMD, Applied Materials) and healthcare picks (Eli Lilly, United Therapeutics, Danaher) as market rotation broadened. Conversely, performance was hampered by weakness in defensive stocks (AutoZone, Comcast, Zoetis) and software names (ServiceNow, Workday) impacted by fears of AI-driven threat to subscription models. Looking forward, with the S&P 500 trading at an elevated forward P/E of 22.1, the manager expects a shift in 2026 towards fundamental earnings delivery and balance-sheet strength, which should benefit the fund's quality-focused positioning.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon